Last reviewed · How we verify
NCT06734026
Multimodal, Enriched Environment for Rehabilitation in Chronic Traumatic Brain Injury
NA trial testing Cafe Therapy in Traumatic Brain Injury (TBI) Patients in 20 participants. Currently enrolling.
15 January 2028
Quick facts
| Lead sponsor | MetroHealth Medical Center |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 8 April 2025 |
| Primary completion | 15 January 2028 |
| Estimated completion | 15 January 2029 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cafe Therapy
Conditions studied
- Traumatic Brain Injury (TBI) Patients — all drugs for Traumatic Brain Injury (TBI) Patients →
Sponsor
MetroHealth Medical Center
Who can join
18 and older, any sex, with Traumatic Brain Injury (TBI) Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to learn if a enhanced environment (Metro Café) with multi model approach (an approach that combines several therapies) in chronic traumatic brain injury improves outcomes of recovery better than traditional therapy. The main questions it aims to answer are: * Determine the amount of therapy dosage (speech, cognition, arm and leg movements) obtained during the Metro Café therapy session. * Evaluate the connection between environmental enrichment dosage (the Metro Café) and clinical outcome scores. Researchers will compare Metro Café Treatment to those who do not receive this treatment to see if better improvements in function after a traumatic brain injury are seen in the Metro Café Treatment Participants will train in the Metro Cafe during the 2-month gap between assessments, for a total of 18 training sessions, each up to 2 hours, 3 times per week. Participants will greet and serve customers drinks and snacks, maintain food supplies at the counters and performs housekeeping tasks with advice and assistance from a supervising researcher as needed,
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06734026
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Traumatic Brain Injury (TBI) Patients
Currently open trials in the same condition.
- NCT07474987 — Portable VR-based Chromatic Pupilloperimeter for Diagnosis and Monitoring of Traumatic Brain Injury · recruiting
- NCT07072624 — Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial) · Phase 4 · recruiting
- NCT06871124 — Early Neuromodulation in Traumatic Brain Injury · NA · recruiting
- NCT07292766 — Metabolomic Profiling of Patients With Traumatic Brain Injury · recruiting
- NCT02030366 — Chromatic Multifocal Pupillometer for Detection and Follow-up of Acute Head Injury · recruiting
Other MetroHealth Medical Center trials
Trials by the same sponsor.
- NCT06788795 — Effectiveness of a Wearable Hydration Device · Phase 2 · not yet recruiting
- NCT06664892 — Ultrahypofractionated Whole Breast Radiation Following Chemotherapy · NA · not yet recruiting
- NCT06836739 — At-Home Genital Nerve Stimulation for SCI Bowel · NA · recruiting
- NCT06113965 — Neural Operant Conditioning · NA · withdrawn
- NCT06635421 — The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06734026 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MetroHealth Medical Center
- Last refreshed: 3 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06734026.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing